Egypt HIV AIDS Industry Outlook 2022 - 2026

See how Egypt HIV AIDS performed compared to key markets such as South Africa, Nigeria and Mozambique.

Key Market Indicators

By 2026, the prevalence of HIV/AIDS in Egypt is estimated to reach 648 people aged 0-14, up 3% each year on average since 1995. In 2021, the country ranked 74th, with 535 people aged 0-14, while Malaysia came first at 535 people. Nigeria, Mozambique and Tanzania came in second, third and fourth respectively. At the same time, treatment coverage of HIV/AIDS in Egypt is expected to reach 58% of those living with HIV in 2026, a 3.9-point increase each year on average since 2009. In 2021, Egypt ranked 110th, with a 46% coverage, while Bhutan came first at 46%. Cape Verde, Latvia and Zimbabwe came in second, third and fourth respectively.

Egypt HIV AIDS Market Data and Forecasts

How much will Egypt HIV AIDS Market grow to 2026?

Forecast: Incidence of Tuberculosis (Including HIV-Positive Cases) in Egypt
Forecast: Incidence of HIV Among People Aged 15-24 in Egypt

Other Top Countries about HIV AIDS